"We specialize in clinical research studies involving paid volunteers. Want to volunteer for a clinical trial? Check out our website to view our current studies and see if you may qualify for a trial. Clinical trials allow medical researchers to evaluate drug effectiveness and safety in a controlled environment. Tucson Neuroscience Research is dedicated to conducting safe and successful studies. Past participants often return to participate in more studies because they enjoyed their experience."

During the past decade, Tucson Neuroscience Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tucson Neuroscience Research" #1 sponsor was "Pfizer" with 2 trials, followed by "ACADIA Pharmaceuticals Inc." with 1 trials sponsored, "Actinogen Medical" with 1 trials sponsored, "Avalo Therapeutics, Inc." with 1 trials sponsored and "Bavarian Nordic" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tucson Neuroscience Research" #1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tucson Neuroscience Research" are "Alzheimer Disease" (3 trials), "Migraine" (3 trials), "Acute Migraine" (1 trials), "Dementia" (1 trials) and "Dementia, Alzheimer Type" (1 trials). Many other conditions were trialed in "Tucson Neuroscience Research" in a lesser frequency.

Most popular intervention types in "Tucson Neuroscience Research" are "Drug" (12 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AVTX-002" (1 trials), "Azeliragon" (1 trials), "CX-8998" (1 trials) and "Dihydroergotamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tucson Neuroscience Research" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Tucson Neuroscience Research". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Tucson Neuroscience Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tucson Neuroscience Research, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".